MDxHealth S.A.

NASDAQ:MDXH

Medical - Diagnostics & Research

Healthcare
$0.60 -4.45%

-$0.03 today

Market cap
$57.59M
Beta
0.38
P/E (TTM)
-1.0
EPS (TTM)
-$0.58
52W Low $0.40High $5.33

Volume 0.65M

Average 4.27M

MDXH Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

MDxHealth S.A.NASDAQ: MDXH

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin narrows to -18.7%

Operating margin was -18.7% in Q2 FY2026, down 11.5 pp from a year earlier. Over 3 fiscal years it widened by 88.0 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 4 analysts of -15.1% for the fiscal year ending Dec 2026, down from -14.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-18.7%— QoQ
Last fiscal yearDec 2025
-14.3%+13.2 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-11.5 pp——
1 year+13.2 pp-0.8 pp-14.0 pp
3 years+88.0 pp+10.2 pp-77.8 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-14.3%
Year-over-year change
+13.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How MDXH compares with its peers on the latest reported figures

  • MDXH's FY2025 operating margin of -14.3% is the 3rd highest of the 9 companies compared; the peer median is -39.1%.
  • Its year-over-year change of +13.2 pp is the 3rd highest of 9, against a peer median of -4.0 pp.
  • Over three fiscal years its change of +88.0 pp compares with a peer median of +20.7 pp.
MDXH Competitors Peer median
Operating Margin for MDXH and competitors
Company Period LTM level YoY 3-year change
SNWVSANUWAVE Health, Inc.LTM Mar 20266.4% -14.2 pp+64.7 pp
NEONeoGenomics, Inc.LTM Jun 2026-8.6% +8.1 pp+21.8 pp
MDXHMDxHealth S.A.FY2025-14.3% +13.2 pp+88.0 pp
ASMBAssembly Biosciences, Inc.LTM Mar 2026-19.1% +119.8 pp—
XGNExagen Inc.LTM Mar 2026-20.6% +4.0 pp+79.9 pp
SIShoulder Innovations, Inc.LTM Mar 2026-57.5% -12.1 pp—
STXSStereotaxis, Inc.LTM Mar 2026-68.5% +25.7 pp-1.6 pp
QTRXQuanterix CorporationLTM Mar 2026-82.7% -35.0 pp+19.6 pp
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-961.9% -168.3 pp-673.9 pp
ZURAZura Bio LimitedFY2025— ——
IMRXImmuneering CorporationFY2025— ——
Peer median (excluding MDXH) -39.1%-4.0 pp+20.7 pp

Competitors are the stored peer set for MDXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue22.24M37.05M70.19M90.05M107.88M
Cost of Revenue11.68M17.84M26.26M34.91M43.43M
Gross Profit10.56M19.22M43.93M55.14M64.44M
Gross Margin47.5%51.9%62.6%61.2%59.7%
Research & Development5.59M7.56M6.38M10.55M10.35M
Selling, General & Admin30.22M50.12M59.93M61.4M66.75M
Operating Expenses37.41M57.12M71.26M79.86M79.84M
Depreciation & Amortization3.04M4.91M6.86M8.04M9.21M
EBITDA(24.09M)(36.39M)(30.47M)(22.02M)(14.01M)
EBITDA Margin-108.3%-98.2%-43.4%-24.5%-13.0%
Operating Income(26.84M)(37.9M)(27.33M)(24.72M)(15.4M)
Operating Margin-120.7%-102.3%-38.9%-27.5%-14.3%
Interest Income11K125K1.09M1.08M1.5M
Interest Expense1.88M2.74M5.77M7.63M12.16M
Other Income / Expenses(2.16M)(6.14M)(15.77M)(12.97M)(19.98M)
Income Before Tax(29M)(44.04M)(43.1M)(37.69M)(35.38M)
Pre-Tax Margin-130.4%-118.9%-61.4%-41.9%-32.8%
Income Tax Expense001K382K(1.86M)
Net Income(29M)(44.04M)(43.1M)(38.07M)(33.52M)
Net Margin-130.4%-118.9%-61.4%-42.3%-31.1%
EPS (Basic)(2.38)(2.78)(1.66)(0.78)(0.67)
EPS (Diluted)(2.38)(2.78)(1.66)(1.16)(0.67)
Weighted Avg Shares12.19M15.87M25.91M48.67M50.03M
Weighted Avg Shares (Diluted)12.19M15.87M25.91M48.67M50.03M

MDxHealth S.A.

NASDAQ:MDXH

Intrinsic Alpha fair value

Locked

Current Price

$0.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.